BENGALURU, June 3 (Reuters) - India's government has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients. Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 p .
BENGALURU Indian shares slipped on Friday at the end of a turbulent week as investors weighed swings in crude oil prices and fast-paced events in the Ukraine…
Indian shares were subdued
on Thursday as investors gauged the impact of higher oil prices
after crude surpassed $120 a barrel, while entertainment giant
Zee jumped after its top investor said it. | March 24, 2022
BENGALURU -Indian shares fell on Tuesday, dragged by heavyweight banking and consumer stocks, with a continued rise in crude oil futures denting sentiment further..